Abstract
In the midst of the COVID-19 pandemic, health care providers have had to rapidly change how they deliver care to patients. We discuss how we are delivering a virtual HIV pre-exposure prophylaxis (PrEP) service during this time; challenges faced; challenges expected and goals for the coming months.
Keywords:
Human immunodeficiency virus; antiretroviral therapy; prevention.
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Aged, 80 and over
-
Ambulatory Care*
-
Anti-HIV Agents / administration & dosage*
-
COVID-19 / epidemiology*
-
COVID-19 / virology
-
Drug Therapy, Combination
-
Emtricitabine / administration & dosage*
-
Female
-
HIV Infections / prevention & control*
-
Humans
-
Ireland / epidemiology
-
Male
-
Middle Aged
-
Pandemics
-
Pre-Exposure Prophylaxis*
-
SARS-CoV-2 / isolation & purification
-
Tenofovir / administration & dosage*
Substances
-
Anti-HIV Agents
-
Tenofovir
-
Emtricitabine